Phase 1

• Conditions: -; MedDRA version: 21.1Level: LLTClassification code 10002321Term: AnesthesiaSystem Organ Class: 100000004852; MedDRA version: 20.0Level: LLTClassification code 10002324Term: Anesthesia injection siteSystem Organ Class: 100000004867; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2021-001854-74-FR
• Lead Sponsor: CHU de Clermont-Ferrand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-12
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

-
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 42
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 42

Exclusion Criteria

-

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified